In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Jacob Laubach discussed his patient's diagnosis of both multiple myeloma and primary amyloidosis and the difficulty in finding a bone marrow donor.

Tags: MultipleMyeloma

  • Dana-Farber is among 16 of the state’s world-leading academic hospitals that will participate in the launch of a new web portal that will connect with life science companies around the world.

Tags: Partnerships

  • Dr. Nikhil Wagle and Dr. Jochen Lorch are featured in a story about "exceptional responders" or patients who have a surprising, dramatic response to a drug.

Tags: OvarianCancer

  • Dr. Robert Haddad provided insight to dispel the myth that cancer cannot spread from person to person.

Tags: HeadNeckCancers, CopingWithCancer

  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center was ranked No. 1 in U.S. News & World Report’s 2015-2016 Best Children's Hospitals in the specialty of cancer.

Tags: ChildhoodCancer

  • Dr. Mehra Golshan and Dr. Yasuaki Sagara led a study that showed surgery for a very early type of breast cancer does not significantly improve outcomes for patients.

Tags: BreastCancer

  • Dr. David Reardon led a study, presented at the American Society of Clinical Oncology (ASCO) meeting, that found adding an experimental, which enlists the immune system to fight cancer to standard therapy, helped patients with the deadliest type of brain cancer live longer.

Tags: ImmuneSystem, BrainTumors

  • Dr. Brian Alexander commented on glioblastoma, the aggressive form of cancer that killed Vice President Joe Biden's son.

Tags: BrainTumors

  • Dr. Pasi A. Janne commented on a new drug that unleashes the body's immune system to attack tumors, which can prolong the lives of people with the most common form of lung cancer.

Tags: ImmuneSystem, LungCancer

  • Dr. Patrick Ott commented on the rapid rise of immunotherapy research.

Tags: Immunotherapy

Showing 21-30 of 582 items